摘要
目的:探讨CYP3A5基因型和伏立康唑对他克莫司用药剂量的影响。方法:临床药师通过对1例狼疮性肾炎患儿进行药学监护,根据CYP3A5基因型对他克莫司初始用药剂量进行估算,联用伏立康唑后,对他克莫司用药剂量进行调整。结果:临床药师通过药学监护,给予个体化的用药建议,提高了患儿用药的安全性和有效性。结论:临床药师在临床个体化给药方案的制定中发挥着积极的作用。
Objective: To probe into the effects of CYP3 A5 genotype and voriconazole on the dosage of tacrolimus. Methods: Clinical pharmacists provided pharmaceutical care for a child with lupus nephritis,and estimated the initial dosage of tacrolimus according to CYP3 A5 genotype. After the drug combination of voriconazole, the dosage of tacrolimus was adjusted. Results: Through the pharmaceutical care,individualized medication recommendations were given to improve the safety and effectiveness of the medication.Conclusion: Clinical pharmacists play an active role in the formulation of individualized clinical dosage regimens.
作者
刘红霞
姜志虎
李志玲
孙华君
Liu Hongxia;Jiang Zhihu;Li Zhiling;Sun Huajun(Shanghai Children's Hospital,Children's Hospital Affiliated to Shanghai Jiaotong University,Shanghai 200062,China)
出处
《儿科药学杂志》
CAS
2018年第11期39-41,共3页
Journal of Pediatric Pharmacy
基金
上海市卫生和计划生育委员会基金,编号20164Y0122
上海交通大学医学院医院药学科研基金青年项目,编号JDYX2016QN017
关键词
药学监护
他克莫司
伏立康唑
pharmaceutical care
tacrolimus
voriconazole